BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33188980)

  • 1. Prognosis of primary hepatic lymphoma: A US population-based analysis.
    Qiu MJ; Fang XF; Huang ZZ; Li QT; Wang MM; Jiang X; Xiong ZF; Yang SL
    Transl Oncol; 2021 Jan; 14(1):100931. PubMed ID: 33188980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, Prognostic Factors and Survival Outcome in Patients With Primary Hepatic Lymphoma.
    Zhang SL; Chen C; Rao QW; Guo Z; Wang X; Wang ZM; Wang LS
    Front Oncol; 2020; 10():750. PubMed ID: 32477954
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary renal lymphoma: a population-based study in the United States, 1980-2013.
    Chen J; Peng J; Zheng Y; Li S; Yang P; Wu X; Tian H; Liu H; Yang S; Wang W; Wu B
    Sci Rep; 2019 Oct; 9(1):15125. PubMed ID: 31641184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and prognostic factors of primary thyroid lymphoma and construction of prognostic models for post-chemotherapy and postoperative patients: a population-based study.
    Xiang N; Dong F; Zhan X; Wang S; Wang J; Sun E; Chen B
    BMC Endocr Disord; 2021 Apr; 21(1):68. PubMed ID: 33849490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological Characteristics and Molecular Phenotypes of Primary Hepatic Lymphoma.
    Xing AY; Dong XZ; Zhu LQ; Liu L; Sun D; Guo S
    Front Oncol; 2022; 12():906245. PubMed ID: 35832546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and Mortality Trends and Risk Prediction Nomogram for Extranodal Diffuse Large B-Cell Lymphoma: An Analysis of the Surveillance, Epidemiology, and End Results Database.
    Yin X; Xu A; Fan F; Huang Z; Cheng Q; Zhang L; Sun C; Hu Y
    Front Oncol; 2019; 9():1198. PubMed ID: 31781500
    [No Abstract]   [Full Text] [Related]  

  • 7. Nomogram for Predicting the Overall Survival of Adult Patients With Primary Gastrointestinal Diffuse Large B Cell Lymphoma: A SEER- Based Study.
    Wang J; Zhou M; Zhou R; Xu J; Chen B
    Front Oncol; 2020; 10():1093. PubMed ID: 32719748
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidemiologic Characteristics, Prognostic Factors, and Treatment Outcomes in Primary Central Nervous System Lymphoma: A SEER-Based Study.
    Tang D; Chen Y; Shi Y; Tao H; Tao S; Zhang Q; Ding B; He Z; Yu L; Wang C
    Front Oncol; 2022; 12():817043. PubMed ID: 35223498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence trends and survival prediction of hepatoblastoma in children: a population-based study.
    Feng J; Polychronidis G; Heger U; Frongia G; Mehrabi A; Hoffmann K
    Cancer Commun (Lond); 2019 Oct; 39(1):62. PubMed ID: 31651371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma.
    Han Y; Yang J; Liu P; He X; Zhang C; Zhou S; Zhou L; Qin Y; Song Y; Sun Y; Shi Y
    Oncologist; 2019 Nov; 24(11):e1251-e1261. PubMed ID: 30952824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary breast diffuse large B-cell lymphoma: a population-based study from 1975 to 2014.
    Jia Y; Sun C; Liu Z; Wang W; Zhou X
    Oncotarget; 2018 Jan; 9(3):3956-3967. PubMed ID: 29423097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence and survival outcomes of patients with primary cardiac lymphoma: A SEER-based analysis.
    Xiao M; Lin J; Xiao T; Lin Y; Ye Y
    Hematol Oncol; 2020 Aug; 38(3):334-343. PubMed ID: 32311106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and nomogram for survival prediction in patients with primary pulmonary lymphoma: a SEER population-based study.
    Low SK; Zayan AH; Istanbuly O; Nguyen Tran MD; Ebied A; Mohamed Tawfik G; Huy NT
    Leuk Lymphoma; 2019 Dec; 60(14):3406-3416. PubMed ID: 31322026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab.
    Gundrum JD; Mathiason MA; Moore DB; Go RS
    J Clin Oncol; 2009 Nov; 27(31):5227-32. PubMed ID: 19770371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI features of primary hepatic lymphoma.
    Colagrande S; Calistri L; Grazzini G; Nardi C; Busoni S; Morana G; Grazioli L
    Abdom Radiol (NY); 2018 Sep; 43(9):2277-2287. PubMed ID: 29460044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
    Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
    World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical management and susceptibility of primary hepatic lymphoma: A cases-based retrospective study.
    Hai T; Zou LQ
    World J Clin Cases; 2021 Nov; 9(31):9417-9430. PubMed ID: 34877277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and outcomes of primary adrenal diffuse large B cell lymphoma in a large contemporary cohort: a SEER-based analysis.
    Li S; Wang Z; Wu Z; Zhuang H; Xu Y
    Ann Hematol; 2019 Sep; 98(9):2111-2119. PubMed ID: 31227873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.
    Castillo JJ; Winer ES; Olszewski AJ
    Am J Hematol; 2014 Mar; 89(3):310-4. PubMed ID: 24273125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram for predicting the overall survival of patients with inflammatory breast cancer: A SEER-based study.
    Pan X; Yang W; Chen Y; Tong L; Li C; Li H
    Breast; 2019 Oct; 47():56-61. PubMed ID: 31351202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.